Physicians' Academy for Cardiovascular Education

How early do we see the CVD benefits of LDL-C lowering?

5' education - Oct. 31, 2018 - Philip Barter, MD - University of New South Wales, Sydney, Australia

Prof. Philip Barter presents an analysis of the relationship between treatment duration and CVD benefits of different LDL-c lowering treatments.

Video navigation menu

  • Benefits of different statins in relation to treatment duration 00:24
  • Comparison of atorvastatin trials versus other statin trials 01:55
  • Does it matter how big the reduction in LDL-c or the primary endpoint is? 03:04
  • What is the effect of non-statins, ezetimibe and PCSK9 inhibitors? 03:46

Share this page with your colleagues and friends: